This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders | MicrobiomeTrials
← Back to trials NCT00001238
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Enrollment target: 5,000 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Ovary Cancer Cervical Cancer Endometrial Cancer
Para-aortic lymphadenectomy plays an important role in the surgical treatment of major gynecological malignancies (ovari…
Guangzhou, China Est. completion May 31, 2028
HIV Cancer Chronic Granulomatous Disease Dock 8 Deficiency
Background:
\- There are very few documents to help young adults living with advanced cancer discuss their concerns and…
Orange, United States Completed Aug 16, 2023
Malignancy, Hematologic Neoplasms, Hematologic Neoplasms, Hematopoietic Blood Cancer Hematological Neoplasms Hematopoietic Malignancies Dysmyelopoietic Syndromes Hematopoetic Myelodysplasia Myeloid Leukemia, Acute Nonlymphoblastic Leukemia, Acute Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United States Est. completion Apr 30, 2029